Ardelyx
Patents, Design & Utilities

Last updated:

List of all Ardelyx patents 27 in total

Status Patent
Grant
Utility: Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders External link
Filling date: 7 Sep 2025 Issue date: 3 May 2022
Application
Utility: GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA External link
Filling date: 7 Sep 2025 Issue date: 7 Apr 2022
Grant
Utility: Compounds useful for treating gastrointestinal tract disorders External link
Filling date: 7 Sep 2025 Issue date: 8 Feb 2022
Application
Utility: HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC MUTAGENIC AND FIBROTIC CONDITIONS AND DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Inhibitors of NHE-mediated antiport External link
Filling date: 7 Sep 2025 Issue date: 19 Oct 2021
Application
Utility: ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORS External link
Filling date: 7 Sep 2025 Issue date: 30 Sep 2021
Grant
Utility: Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators External link
Filling date: 7 Sep 2025 Issue date: 17 Aug 2021
Application
Utility: NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT External link
Filling date: 7 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA External link
Filling date: 7 Sep 2025 Issue date: 3 Jun 2021
Grant
Utility: Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists External link
Filling date: 7 Sep 2025 Issue date: 6 Apr 2021
Grant
Utility: NHE3-binding compounds and methods for inhibiting phosphate transport External link
Filling date: 7 Sep 2025 Issue date: 9 Mar 2021
Application
Utility: HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: METHODS FOR INHIBITING PHOSPHATE TRANSPORT External link
Filling date: 7 Sep 2025 Issue date: 26 Nov 2020
Grant
Utility: Hormone receptor modulators for treating metabolic conditions and disorders External link
Filling date: 7 Sep 2025 Issue date: 6 Oct 2020
Application
Utility: COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS External link
Filling date: 7 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT External link
Filling date: 7 Sep 2025 Issue date: 6 Feb 2020
Grant
Utility: Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders External link
Filling date: 7 Sep 2025 Issue date: 28 Jan 2020
Application
Utility: INHIBITORS OF NHE-MEDIATED ANTIPORT External link
Filling date: 7 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 28 Nov 2019
Application
Utility: ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORS External link
Filling date: 7 Sep 2025 Issue date: 10 Oct 2019
Application
Utility: NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT External link
Filling date: 7 Sep 2025 Issue date: 12 Sep 2019
Grant
Utility: Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists External link
Filling date: 7 Sep 2025 Issue date: 27 Aug 2019
Grant
Utility: Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders External link
Filling date: 7 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders External link
Filling date: 7 Sep 2025 Issue date: 13 Aug 2019
Application
Utility: HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 1 Aug 2019

Showing 1 to 27 of 27 patents.